Nasimuzzaman M - Search Results

1

Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.

Nasimuzzaman M, Lynn D, Ernst R, Beuerlein M, Smith RH, Shrestha A, Cross S, Link K, Lutzko C, Nordling D, Russell DW, Larochelle A, Malik P, Van der Loo JC. Nasimuzzaman M, et al. Mol Ther Methods Clin Dev. 2016 Mar 16;3:16004. doi: 10.1038/mtm.2016.4. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27722179 Free PMC article.

2

Purification of baculovirus vectors using heparin affinity chromatography.

Nasimuzzaman M, Lynn D, van der Loo JC, Malik P. Nasimuzzaman M, et al. Mol Ther Methods Clin Dev. 2016 Dec 7;3:16071. doi: 10.1038/mtm.2016.71. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27933303 Free PMC article.

3

Production and Purification of Baculovirus for Gene Therapy Application.

Nasimuzzaman M, van der Loo JCM, Malik P. Nasimuzzaman M, et al. J Vis Exp. 2018 Apr 9;(134):57019. doi: 10.3791/57019. J Vis Exp. 2018. PMID: 29683451 Free PMC article.

4

Process Development for the Production and Purification of Adeno-Associated Virus (AAV)2 Vector using Baculovirus-Insect Cell Culture System.

Nasimuzzaman M, Villaveces S, van der Loo JCM, Alla S. Nasimuzzaman M, et al. J Vis Exp. 2022 Jan 13;(179). doi: 10.3791/62829. J Vis Exp. 2022. PMID: 35098946

5

Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.

Smith RH, Bloomer H, Fink D, Keyvanfar K, Nasimuzzaman M, Sancheznieto F, Dutta R, Guenther Bui K, Alvarado LJ, Bauer TR Jr, Hickstein DD, Russell DW, Malik P, van der Loo JCM, Highfill SL, Kuhns DB, Pirooznia M, Larochelle A. Smith RH, et al. Among authors: nasimuzzaman m. Hum Gene Ther. 2022 Dec;33(23-24):1293-1304. doi: 10.1089/hum.2022.065. Epub 2022 Nov 1. Hum Gene Ther. 2022. PMID: 36094106 Free PMC article.

6

Role of the coagulation system in the pathogenesis of sickle cell disease.

Nasimuzzaman M, Malik P. Nasimuzzaman M, et al. Blood Adv. 2019 Oct 22;3(20):3170-3180. doi: 10.1182/bloodadvances.2019000193. Blood Adv. 2019. PMID: 31648337 Free PMC article.

7

High-titer foamy virus vector transduction and integration sites of human CD34(+) cell-derived SCID-repopulating cells.

Nasimuzzaman M, Kim YS, Wang YD, Persons DA. Nasimuzzaman M, et al. Mol Ther Methods Clin Dev. 2014 Jun 4;1:14020. doi: 10.1038/mtm.2014.20. eCollection 2014. Mol Ther Methods Clin Dev. 2014. PMID: 26015964 Free PMC article.

8

Elimination of the fibrinogen integrin α_Mβ₂-binding motif improves renal pathology in mice with sickle cell anemia.

Nasimuzzaman M, Arumugam PI, Mullins ES, James JM, VandenHeuvel K, Narciso MG, Shaw MA, McGraw S, Aronow BJ, Malik P. Nasimuzzaman M, et al. Blood Adv. 2019 May 14;3(9):1519-1532. doi: 10.1182/bloodadvances.2019032342. Blood Adv. 2019. PMID: 31076408 Free PMC article.

9

Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells.

Nasimuzzaman M, Persons DA. Nasimuzzaman M, et al. Mol Ther. 2012 Jun;20(6):1158-66. doi: 10.1038/mt.2012.41. Epub 2012 Mar 20. Mol Ther. 2012. PMID: 22434139 Free PMC article.

10

Purification of Platelets from Mouse Blood.

Narciso MG, Nasimuzzaman M. Narciso MG, et al. Among authors: nasimuzzaman m. J Vis Exp. 2019 May 7;(147). doi: 10.3791/59803. J Vis Exp. 2019. PMID: 31132069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters